Pfizer (XTER:PFE) Forward PE Ratio : 9.12 (As of Dec. 11, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Pfizer Forward PE Ratio?

Pfizer's Forward PE Ratio for today is 9.12.

Pfizer's PE Ratio without NRI for today is 9.91.

Pfizer's PE Ratio (TTM) for today is 34.55.

Pfizer Forward PE Ratio Historical Data

The historical data trend for Pfizer's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Forward PE Ratio Chart

Pfizer Annual Data

Trend

2015-12

2016-12

2017-12

2018-12

2019-12

2020-12

2021-12

2022-12

2023-12

2024-12

Forward PE Ratio

13.76

12.39

13.25

13.95

13.77

12.63

11.40

10.27

12.85

8.93

Pfizer Quarterly Data
	2015-12	2016-03	2016-06	2016-09	2016-12	2017-03	2017-06	2017-09	2017-12	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-03	2022-06	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12	2024-03	2024-06	2024-09	2024-12
Forward PE Ratio	13.76	11.96	14.53	13.00	12.39	13.51	13.19	12.85	13.25	11.93	12.25	14.20	13.95	14.53	14.95	12.29	13.77	11.44	11.22	11.70	12.63	11.24	10.82	12.20	11.40	7.78	7.63	9.34	10.27	11.85	10.83	9.94	12.85	12.41	12.14	10.36	8.93

Competitive Comparison of Pfizer's Forward PE Ratio

For the Drug Manufacturers - General subindustry, Pfizer's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pfizer's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Forward PE Ratio falls into.

Pfizer Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Pfizer (XTER:PFE) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Pfizer Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Pfizer's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XTER:PFE) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK PFEB:Germany PFE:Germany PFE:Germany PFE:Germany PFE:Canada PFIZ34:Brazil PFE:Bulgaria PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.